And a decade later, after watching authors tirelessly self-market online, I find myself wishing that writers still had the ...
Ipsen presents 3 late-breaking presentations and 8 abstracts across rare cholestatic liver disease portfolio at AASLD 2024Iqirvo approved for use ...